IBOV 166,334.86 ▼ 0.27% IPSA 11,186.57 ▲ 0.34% IPC MEX 64,301.04 ▲ 0.07% MERVAL 2,891,651 ▼ 1.89% COLCAP 2,461.23 ▲ 0.36% BVL PERÚ 58,401.58 ▼ 1.35% USD/BRL5.21▲ 0.22% USD/MXN17.06▲ 0.13% USD/CLP927.14▲ 1.17% USD/COP3,098▼ 1.01% USD/PEN3.37▼ 0.03% USD/ARS1,495▲ 0.45% USD/UYU40.26▲ 1.93% USD/PYG6,002▲ 2.02% USD/BOB11.48▲ 0.10% USD/DOP58.50▲ 1.26% USD/CRC444.65▲ 1.69% USD/GTQ7.62▲ 2.33% USD/HNL26.80▲ 1.74% USD/NIO36.62▲ 0.81% USD/VES771.38▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.71▲ 1.08% EUR/BRL6.03▼ 0.07% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 166,334.86 ▼ 0.27% IPSA 11,186.57 ▲ 0.34% IPC MEX 64,301.04 ▲ 0.07% MERVAL 2,891,651 ▼ 1.89% COLCAP 2,461.23 ▲ 0.36% BVL PERÚ 58,401.58 ▼ 1.35% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Tuesday, August 18, 2026

Brazil Politics - Brazil

Investigation into pandemic is pebble in Bolsonaro’s shoe

By · April 28, 2021 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – The Brazilian Senate this Tuesday formed a committee to investigate potential omissions by President Jair Bolsonaro’s government in the face of the Covid-19 pandemic; the committee is controlled by the opposition and will be from now on a pebble in the president’s shoe.

The committee, with 11 full members and 7 alternates, has only 4 senators aligned with Bolsonaro and will determine whether the government has any responsibility in the worsening of the health crisis, when Brazil is nearing 400,000 deaths and has doubled in this year’s first four months the total number of deaths in 2020.

Omar Aziz, Randolfe Rodrigues and Renan Calheiros. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The group will be able to summon ministers and other authorities to testify and, in fact, it has already proposed to question the head of the Health Ministry Marcelo Queiroga, and his 3 predecessors, who succeeded each other in office amid the pandemic.

In the first session, the commission’s board of directors was elected: it will be chaired by Omar Aziz, of the Social Democratic Party (PSD), a center party which declares itself to be independent.

Senator Randolfe Rodrigues, of the ecologist Rede party and one of Bolsonaro’s harshest critics in Parliament, was elected vice-president.

The position of rapporteur, key to the course of the investigation, was attributed to Renan Calheiros, of the Brazilian Democratic Movement (MDB), a center-right party that does not conceal its oppositionist nature.

BOLSONARISM’S FIRST DEFEAT IN THE COMMISSION

Bolsonarism tried to prevent Calheiros’ election as rapporteur through judicial channels, using the argument that the senator has already declared his conviction that Bolsonaro has been “omissive”, “denialist” and “incompetent” in the face of the pandemic.

However, the majority prevailed in a committee that will have 90 days to conduct the investigation, although it may be extended, and must conclude with a report that, according to its conclusions, may be referred to the public prosecutor’s office for the initiation of a judicial proceeding.

The Government’s concern lies in the purely political nature of the work, which will also be conducted at a time when the pandemic is far from subsiding and with parties and Bolsonaro starting to focus on the October 2022 elections, in which the president will seek reelection.

Aziz, in his first statement as president of the commission, urged to avoid “political discussions” and that an “anticipated electoral climate contaminates” the investigative work.

“There are surveys showing that 86% of Brazilians know someone who died of Covid. We cannot have political discussions with 400,000 dead,” he emphasized.

LONG LIST OF POTENTIAL OMISSIONS AND IRREGULARITIES

The denialism shown by Bolsonaro since the very beginning of the pandemic has been worrying some sectors of the ruling party for months.

With the start of investigation, the government has made it clear that it shares this concern through an internal document, which was obtained by local media and lists 23 possible cases of omission or irregularities in the fight against the pandemic, about which the commission will now ask for explanations.

The document was drawn up with the goal of preparing a defense in the Senate committee, before which a long list of ministers and former Bolsonaro collaborators is expected to be paraded.

Some of these points of doubt refer to the Health Ministry’s refusal to start the process of purchasing vaccines mid-last year, or Bolsonaro’s reluctance to concede to the severity of a virus that he went so far as to call a “minor flu.”

Delays are also cited in the purchase of oxygen or intubation drugs, which are still scarce in some regions of the country and aggravate the hospital situation.

Other points refer to the spread of false news about the pandemic, the lack of an official awareness campaign about its severity, and Bolsonaro’s pressures for the use of drugs with no proven efficacy against the coronavirus, such as chloroquine, in the public health network.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.